These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 13446

  • 21. Inhibition of apomorphine-induced climbing in mice by cholinergic drugs and neuroleptics.
    Lassen JB.
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):161-5. PubMed ID: 40391
    [Abstract] [Full Text] [Related]

  • 22. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
    Gray AM, Connick JH.
    Eur J Pharmacol; 1998 Dec 04; 362(2-3):127-36. PubMed ID: 9874162
    [Abstract] [Full Text] [Related]

  • 23. Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.
    Sayers AC, Bürki HR, Ruch W, Asper H.
    Psychopharmacologia; 1975 Dec 04; 41(2):97-104. PubMed ID: 1171492
    [Abstract] [Full Text] [Related]

  • 24. Effect of antipsychotic drugs on homovanillic acid levels in striatum and olfactory tubercle of the rat.
    Wiesel FA, Sedvall G.
    Eur J Pharmacol; 1975 Feb 04; 30(2):364-7. PubMed ID: 236193
    [Abstract] [Full Text] [Related]

  • 25. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I, Kawano M, Kaneyuki H, Suetsugi M, Usami K, Hirano H, Mizuki Y, Yamada M.
    Pharmacol Biochem Behav; 1997 Sep 04; 58(1):103-8. PubMed ID: 9264077
    [Abstract] [Full Text] [Related]

  • 26. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
    Robertson GS, Fibiger HC.
    Neuroscience; 1992 Sep 04; 46(2):315-28. PubMed ID: 1347406
    [Abstract] [Full Text] [Related]

  • 27. The transcription factor NGFI-B (Nur77) and retinoids play a critical role in acute neuroleptic-induced extrapyramidal effect and striatal neuropeptide gene expression.
    Ethier I, Beaudry G, St-Hilaire M, Milbrandt J, Rouillard C, Lévesque D.
    Neuropsychopharmacology; 2004 Feb 04; 29(2):335-46. PubMed ID: 14603264
    [Abstract] [Full Text] [Related]

  • 28. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G.
    J Pharmacol Exp Ther; 1998 Sep 04; 286(3):1341-55. PubMed ID: 9732398
    [Abstract] [Full Text] [Related]

  • 29. Effects of fluperlapine on dopaminergic systems in rat brain.
    Burki HR.
    Psychopharmacology (Berl); 1986 Sep 04; 89(1):77-84. PubMed ID: 2942961
    [Abstract] [Full Text] [Related]

  • 30. The relationship of pharmacology to side effects.
    Casey DE.
    J Clin Psychiatry; 1997 Sep 04; 58 Suppl 10():55-62. PubMed ID: 9265918
    [Abstract] [Full Text] [Related]

  • 31. Differential effects of acute administration of haloperidol and clozapine on ethanol-induced ascorbic acid release in rat striatum.
    Liu W, Wu CF, Liu J, Huang M, Xiao K.
    Eur J Pharmacol; 2000 Jun 23; 398(3):333-9. PubMed ID: 10862822
    [Abstract] [Full Text] [Related]

  • 32. Biochemical methods for predicting the occurrence of tardive dyskinesia.
    Bürki HR.
    Commun Psychopharmacol; 1979 Jun 23; 3(1):7-15. PubMed ID: 38033
    [No Abstract] [Full Text] [Related]

  • 33. Effect of the new gamma-aminobutyric acid agonist SL 76 002 on striatal acetylcholine: relation to neuroleptic-induced extrapyramidal alterations.
    Bartholini G, Scatton B, Zivkovic B.
    Adv Biochem Psychopharmacol; 1980 Jun 23; 24():207-13. PubMed ID: 6105775
    [Abstract] [Full Text] [Related]

  • 34. Differential effects of the antipsychotics haloperidol and clozapine on G protein measures in mononuclear leukocytes of patients with schizophrenia.
    Avissar S, Roitman G, Schreiber G.
    Cell Mol Neurobiol; 2001 Dec 23; 21(6):799-811. PubMed ID: 12043849
    [Abstract] [Full Text] [Related]

  • 35. Effect of ritanserin on the interaction of amfonelic acid and neuroleptic-induced striatal dopamine metabolism.
    Brougham LR, Conway PG, Ellis DB.
    Neuropharmacology; 1991 Oct 23; 30(10):1137-40. PubMed ID: 1684649
    [Abstract] [Full Text] [Related]

  • 36. Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine.
    Wilk S, Watson E, Stanley ME.
    J Pharmacol Exp Ther; 1975 Nov 23; 195(2):265-70. PubMed ID: 1185596
    [Abstract] [Full Text] [Related]

  • 37. Catalepsy induced by morphine or haloperidol: effects of apomorphine and anticholinergic drugs.
    Erzin-Waters C, Muller P, Seeman P.
    Can J Physiol Pharmacol; 1976 Aug 23; 54(4):516-9. PubMed ID: 10058
    [Abstract] [Full Text] [Related]

  • 38. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
    Bettini E, Ceci A, Spinelli R, Samanin R.
    Biochem Pharmacol; 1987 Jul 15; 36(14):2387-91. PubMed ID: 2886127
    [Abstract] [Full Text] [Related]

  • 39. Clozapine antagonizes the induction of striatal Fos expression by typical neuroleptics.
    Wirtshafter D.
    Eur J Pharmacol; 1998 Oct 09; 358(3):R1-3. PubMed ID: 9822897
    [Abstract] [Full Text] [Related]

  • 40. The pathophysiology of tardive dyskinesia.
    Klawans HL, Carvey P, Tanner CM, Goetz CG.
    J Clin Psychiatry; 1985 Apr 09; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.